Health ❯Respiratory Conditions
Medical Treatment COVID-19 COPD Dust Exposure Allergies Severe Asthma Exacerbation Childhood Asthma Allergic Rhinitis Emphysema Severe Exacerbation
Humanization of the XA19 antibody is underway with clinical trials targeted to begin in two to three years.